Mycotoxins in Urine (Mold Exposure Test)

Beschrijving

Why test mycotoxins

Indoor mold exposure is more common than many people realise and can contribute to persistent, multi-system symptoms. Mycotoxins are biologically active compounds produced by certain molds and can affect inflammation, neurological signalling, energy metabolism, and detoxification capacity.

This test helps identify whether recent or ongoing mycotoxin exposure may be contributing to your clinical picture and whether a targeted environmental and metabolic approach is appropriate.

What this test measures

Our Urine Mycotoxins Panel measures a set of clinically relevant mycotoxins commonly associated with indoor environments and dietary exposures.

Typical groups assessed include:

• Ochratoxins
• Aflatoxins
• Trichothecenes
• Gliotoxin-related markers (where applicable)

When this test is clinically useful

Consider mycotoxin testing when symptoms persist and the history suggests possible mold exposure (home, workplace, water damage, old buildings, vehicles) or when progress is limited despite standard interventions.

Common symptom patterns reported in mold-associated casework can include:

• Chronic fatigue and reduced resilience
• Brain fog, cognitive complaints, concentration issues
• Headaches
• Mood symptoms (anxiety, low mood)
• Sinus or nasal congestion, cough, shortness of breath
• Digestive issues
• Skin issues (eczema, acne flares)
• Unexplained nutrient deficiencies

Associated clinical contexts sometimes explored alongside mold exposure include asthma-like symptoms, inflammatory bowel symptoms, metabolic dysregulation, and neuroinflammatory presentations.

Important note (good for compliance): Mycotoxin testing supports clinical investigation, but results must be interpreted in context. A positive test does not identify the exact source of exposure, and a negative test does not fully exclude prior exposure.

Stronger insights when combined

In practice, the most clinically actionable approach is often to combine:

1. Mycotoxins in urine (exposure assessment)
   with
2. Organic Acids in urine (metabolic impact assessment)

This combination helps clarify how exposure may be affecting:

• Energy production and mitochondrial function
• Detoxification pathways
• Oxidative stress balance
• Nutritional and microbial metabolic markers

WHL option: “Myco-Metabolic Insight Panel” (Urine Mycotoxins + Organic Acids)

What you receive

You will receive:

• Quantitative results for measured mycotoxins

• Reference ranges

Sample type and collection

• Sample requirement: Morning urine collection preferred

Suitable for postal submission.